IL2 and Alzheimer disease: Similarly, overexpression of miR-186 in AD inhibits the JAK-STAT signaling pathway and downregulates interleukin-2 (IL-2) to reduce inflammation, promote cell proliferation, and reduce A levels to improve hippocampal neuronal cell viability [161].